Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.
Oxford University\u2019s Professor Teresa Lambe, the designer of the vaccine, fears Marburg disease is \u2018now being seen in places where it\u2019s never been seen before\u2019
When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
A celebration for the opening of our Institute took place on Tuesday 12 July 2022 in the IMS-Tetsuya Nakamura Building, which was supported by a very generous donation from Dr Tetsuya Nakamura, Chief Director of Itabashi Medical System Group (IMS-Group), and substantial fund-raising from the British Heart Foundation (BHF).
Researchers from Oxford\u2019s Department of Paediatrics have discovered that infection can increase a baby\u2019s sensitivity to pain, which may last longer than the infection.
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
The James Spence Medal is the highest honour awarded by the RCPCH, and is awarded for outstanding contributions to the advancement of knowledge and understanding in paediatrics and child health.
On Wednesday 15th June, the Department of Paediatrics invited its members of staff and selected guests to join them at the Oxford University Museum of Natural History to embark on special evening of celebrations, commemoration, and entertainment.
It is a tragedy for a child to be diagnosed with a severe and disabling lifelong medical condition. But in addition to the child\u2019s difficulties and suffering and the emotional cost to their family, such maladies can also create a significant financial cost to both the family and to society; whether due to the cost of treatments, the expense of medical equipment and home adaptations, or indeed the loss of a family\u2019s productivity.
Teens should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the U.K.
Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 \u2013 with a focus on assessing different options for a third dose booster vaccination.
Skeletal muscle, which accounts for over 40% of the total mass in healthy individuals, plays a central role in maintenance of organismal homeostasis. Conversely, muscle atrophy upon acute and chronic conditions, ranging from genetic muscular dystrophy to critical illnesses, cachexia and sarcopenia, significantly correlates with levels of disability and is an important predictor of mortality. Despite the urgent medical need, treatments able to efficiently counteract muscle loss are lacking due to an incomplete understanding of the underlying intricate molecular mechanisms of regulation.
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull \u201cstructural\u201d cells, are much more complex than previously thought.
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.
The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.
The Oxford Vaccine Group\u2019s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.
The KEMRI Wellcome Trust Research Programme (KWTRP) is based within the KEMRI Centre for Geographic Medical Research \u2013 (Coast). The core activities are funded by the Wellcome Trust. They conduct integrated epidemiological, social, laboratory and clinical research in parallel, with results feeding into local and international health policy.
Friday 29 April is International Day of Immunology, an opportunity to raise global awareness of the importance of immunology in the fight against disease. Immunology research at the IDRM focuses on revealing the fundamental mechanisms that dictate the development and function of our immune system\u2019s ability to efficiently respond to harmful antigens, while being tolerant towards the body\u2019s own tissues.
The campaign theme for this year is #BreakTheBias. Celebrate women's achievement. Raise awareness against bias. Take action for equality. Today, we celebrate the achievements of several of IDRM\u2019s women over the past year.
In the UK, every 5 days a baby is born with SMA. Treatments are available now. If these treatments are delivered at birth, these newborns have the best chance of living long and healthy lives. If treated later, when they are identified because of the symptoms, they may survive, but with a severe disability. So, for every 5 days that a newborn screening is delayed, a baby in the UK loses the chance of a brighter future. \r\nOxford University is initiating a population-based newborn screening study in the Thames Valley. This study aims to make it possible to detect SMA within days of birth, before symptoms develop, so that any affected newborn can receive diagnosis and treatment at the earliest possible opportunity. We hope that it will pave the way for a national newborn screening that will save about 70 babies/year in the UK from disability
![\"\"](\"https://www.paediatrics.ox.ac.uk/news/oxford-scientists-honoured-with-eight-royal-society-awards/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n